This subtype shows constitutive up‐regulation of the nuclear factor kappa light‐chain enhancer of activated B cells (NF‐κB) pathway, which has been implicated in chemoresistance and tumor progression in multiple cancer types including urothelial cancer [9, 10, 11]. This evidence concerns the gene NFKB1 and cancer.